Ganoderan, one of the components of G. lucidum polysaccharides, was reported to regulate the growth, motility and apoptosis of non-small cell lung cancer cells through the Ras/Raf/MEK/ERK signaling pathway (Wang et al., 2019). Here, MAP2K7 is linked to non-small cell lung carcinoma.